March-in campaign on Pfizer’s prostate cancer med Xtandi gets congressional backing. Will it matter?
March-in campaign on Pfizer’s prostate cancer med Xtandi gets congressional [...]
Novartis’ Leqvio to reap $2.5B by 2027 thanks to convenience edge over Amgen, Sanofi rivals: analyst
Novartis’ Leqvio to reap $2.5B by 2027 thanks to convenience [...]
Sandoz launches generic Revlimid in 19 countries in Europe, opening a flood of competition for BMS’ megablockbuster
Sandoz launches generic Revlimid in 19 countries in Europe, opening [...]
Roche settles lawsuit claiming AstraZeneca’s Ultomiris infringes delivery patent
Roche settles lawsuit claiming AstraZeneca’s Ultomiris infringes delivery patent aliu [...]
Sanofi, Regeneron ditch Dupixent trial vs. Novartis and Roche’s Xolair for hives condition
Sanofi, Regeneron ditch Dupixent trial vs. Novartis and Roche’s Xolair [...]
Sanofi, Regeneron ditch Dupixent trial in patients who failed Novartis and Roche’s Xolair for hives condition
Sanofi, Regeneron ditch Dupixent trial in patients who failed Novartis [...]
Recipharm, working on Moderna’s COVID vaccine, boosts biologics presence with Arranta Bio, Vibalogics buyouts
Recipharm, working on Moderna’s COVID vaccine, boosts biologics presence with [...]
J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn’s data
J&J lands Tremfya one-two punch in IBD with first ulcerative [...]
Fierce Pharma Asia—Lilly, Innovent’s I-O implications; Novartis’ India job cuts; Moderna’s Asia expansion
Fierce Pharma Asia—Lilly, Innovent’s I-O implications; Novartis’ India job cuts; [...]
Organon CEO pins high hopes on upcoming Humira biosimilar launch
Organon CEO pins high hopes on upcoming Humira biosimilar launch [...]